Entropy Technologies LP Acquires Shares of 14,767 Humana Inc. (NYSE:HUM)

Entropy Technologies LP bought a new position in Humana Inc. (NYSE:HUM - Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 14,767 shares of the insurance provider's stock, valued at approximately $4,677,000.

Several other institutional investors have also recently made changes to their positions in HUM. Creative Financial Designs Inc. ADV lifted its stake in Humana by 244.0% during the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider's stock valued at $27,000 after acquiring an additional 61 shares in the last quarter. CarsonAllaria Wealth Management Ltd. lifted its position in shares of Humana by 111.4% in the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider's stock worth $28,000 after purchasing an additional 39 shares during the period. Atwood & Palmer Inc. purchased a new position in shares of Humana during the third quarter valued at approximately $29,000. Ashton Thomas Securities LLC purchased a new position in Humana in the 3rd quarter worth about $31,000. Finally, Your Advocates Ltd. LLP boosted its holdings in shares of Humana by 81.8% in the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider's stock worth $32,000 after buying an additional 45 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on HUM. KeyCorp began coverage on shares of Humana in a research note on Friday, October 11th. They issued a "sector weight" rating on the stock. Truist Financial cut their price target on Humana from $400.00 to $260.00 and set a "hold" rating for the company in a report on Friday, October 11th. Barclays upped their target price on shares of Humana from $250.00 to $253.00 and gave the stock an "equal weight" rating in a research note on Thursday, October 31st. Leerink Partnrs downgraded Humana from a "strong-buy" rating to a "hold" rating in a report on Wednesday, October 2nd. Finally, Cantor Fitzgerald reaffirmed a "neutral" rating and set a $395.00 price objective on shares of Humana in a research note on Tuesday, October 1st. Twenty investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $315.86.

Humana Stock Performance

Shares of NYSE:HUM traded down $2.38 during midday trading on Tuesday, reaching $280.06. 1,600,041 shares of the company's stock traded hands, compared to its average volume of 1,872,915. The company has a market cap of $33.72 billion, a price-to-earnings ratio of 25.02, a P/E/G ratio of 2.28 and a beta of 0.52. Humana Inc. has a one year low of $213.31 and a one year high of $527.18. The stock has a 50 day moving average of $287.94 and a 200 day moving average of $332.62. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76.

Humana (NYSE:HUM - Get Free Report) last released its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, topping analysts' consensus estimates of $3.48 by $0.68. The firm had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. As a group, equities research analysts anticipate that Humana Inc. will post 15.83 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.26%. The ex-dividend date is Tuesday, December 31st. Humana's dividend payout ratio is presently 31.36%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.